Related Experiment Videos
Recurrent Henoch-Schönlein purpura in children
Dario Prais1, Jacob Amir, Moshe Nussinovitch
1Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. dariop@clalit.org.il
Insights
Recurrent Henoch-Schönlein purpura (HSP) in children is uncommon, with no clear predictors for recurrence. Second episodes may be longer, but prognosis remains good.
Area of Science:
- Pediatrics
- Rheumatology
- Immunology
Background:
- Henoch-Schönlein purpura (HSP), or anaphylactoid purpura, is a systemic vasculitis primarily affecting children aged 3-10 years.
- Recurrent episodes of HSP, while not common, warrant investigation into associated clinical and epidemiological factors.
Purpose of the Study:
- To characterize the clinical, epidemiological, and laboratory findings in pediatric patients experiencing recurrent Henoch-Schönlein purpura.
- To identify potential predictors for HSP recurrence in a hospitalized pediatric cohort.
Main Methods:
- Retrospective analysis of medical records for children hospitalized with HSP between 1969 and 2004.
- Comparison of demographic and clinical characteristics between patients with single and recurrent HSP episodes.
Main Results:
- Out of 260 children hospitalized for HSP, only 7 (2.7%) experienced recurrence.
- No significant differences in demographics or clinical presentation were found between single and recurrent HSP cases.
- The second HSP episode was longer than the first, with a mean interval of 13.5 months between episodes.
Conclusions:
- No clinical or laboratory factors reliably predicted recurrent Henoch-Schönlein purpura in this inpatient pediatric population.
- Recurrent HSP episodes can be prolonged, and the interval between episodes may be longer than previously reported.
- Despite recurrence, Henoch-Schönlein purpura generally has a favorable prognosis in hospitalized children.
Background:
Henoch-Schönlein purpura (HSP), also known as anaphylactoid purpura is a clinically recognizable systemic disorder occurring in children, mainly from ages 3 to 10 years.
Objectives:
To describe the clinical, epidemiological, and laboratory findings in a group of patients with recurrent HSP, admitted to a tertiary pediatric center.
Methods:
Retrospective analysis of medical records of patients hospitalized due to HSP between 1969 and 2004.
Results:
Two hundred sixty children (56.7% males) were hospitalized due to HSP, 7 (2.7%) more than once. There were no statistically significant differences in demographic or clinical characteristics between the patients with 1 event of HSP and patients with recurrence. Mean age of the subgroup with recurrence was 3.67 years (10 months to 7.4 years) at the first episode, and 5.03 years (2.2-10 years) at the second one, with a mean lag period of 13.5 +/- 2.8 months (range 2-26). The duration of the recurrent clinical symptoms ranged from 9 to 30 days, and in 72% of those patients, resolution took more than 14 days.
Conclusion:
In our inpatient population, no clinical or laboratory characteristics were found to be predictive of recurrence; the second episode was longer than the first and the lag period between the 2 episodes was substantially longer than previously reported. Hospital admissions for recurrent HSP are not common. Nevertheless, a good prognosis was the rule of our admitted patients.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease I: Introduction
Peptic Ulcer
Chickenpox